Mitochondrial targeting improves the selectivity of singlet‐oxygen cleavable prodrugs in NMIBC treatment
Photochemistry and Photobiology · 2024
DOI: 10.1111/php.13928 ↗At a glance
Journal article in Photochemistry and Photobiology, 2024. Written by Kazi Md Mahabubur Rahman and 5 co-authors. Institution: Department of Pharmaceutical Sciences, University at Buffalo, The State University of New York, Buffalo, New York, USA. Major MEDLINE topics: Prodrugs, Mitochondria, Singlet Oxygen, Urinary Bladder Neoplasms. Cited 5 times so far (Crossref); 35 references. The full text is freely available in PubMed Central. Funded by: NCI NIH HHS, The National Cancer Institute, The Department of Defense.
Abstract (original language)
Mitochondria play an essential role in cancer treatment by providing apoptotic signals. Hexyl aminolevulinate, an FDA‐approved diagnosis for non‐muscle invasive bladder cancer, induces the production of protoporphyrin IX (PpIX) preferentially by mitochondria in cancer cells. Photosensitizer PpIX upon illumination can release active chemotherapy drugs from singlet oxygen‐activatable prodrugs. Prodrugs placed close enough to PpIX formed in mitochondria can improve the antitumor efficiency of PpIX‐PDT. The preferred uptake of prodrugs by cancer cells and tumors can further enhance the selective damage of cancer cells over non‐cancer cells and surrounding normal tissues. Mitochondriotropic prodrugs of anticancer drugs, such as paclitaxel and SN‐38, were synthesized using rhodamine, a mitochondrial‐targeting moiety. In vitro, the mitochondrial targeting helped achieve preferential cellular uptake in cancer cells. In RT112 cells (human bladder cancer cells), intracellular prodrug concentrations were 2–3 times higher than the intracellular prodrug concentrations in BdEC cells (human bladder epithelial cells), after 2 h incubation. In an orthotopic rat bladder tumor model, mitochondria‐targeted prodrugs achieved as much as 34 times higher prodrug diffusion in the tumor area compared to the nontumor bladder area. Overall, mitochondria targeting made prodrugs more effective in targeting cancer cells and tumors over non‐tumor areas, thereby reducing nonspecific toxicity.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmaceutical Sciences, University at Buffalo, The State University of New York, Buffalo, New York, USA.
- Department of Pharmacology & Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
ORCID profiles: Youngjae You
Funding
- NCI NIH HHS
- The National Cancer Institute
- The Department of Defense
- U.S. Department of Defense
Cite
APA
Rahman, K. M. M., Bist, G., Kumbham, S., Foster, B. A., Woo, S., & You, Y. (2024). Mitochondrial targeting improves the selectivity of singlet‐oxygen cleavable prodrugs in NMIBC treatment. Photochemistry and Photobiology. https://doi.org/10.1111/php.13928
Vancouver
Rahman KMM, Bist G, Kumbham S, Foster BA, Woo S, You Y. Mitochondrial targeting improves the selectivity of singlet‐oxygen cleavable prodrugs in NMIBC treatment. Photochemistry and Photobiology. 2024. doi:10.1111/php.13928
BibTeX
@article{Rahman2024,
author = {Rahman, Kazi Md Mahabubur and Bist, Ganesh and Kumbham, Soniya and Foster, Barbara A and Woo, Sukyung and You, Youngjae},
title = {Mitochondrial targeting improves the selectivity of singlet‐oxygen cleavable prodrugs in NMIBC treatment},
journal = {Photochemistry and Photobiology},
year = {2024},
doi = {10.1111/php.13928}
}
EUVIMED